Then, we asked whether high‐EDEM3 expression in tumour cells would affect the response to immunotherapy by analysing CRC patient responses to the PD‐1 antibody using the Gene Expression Omnibus (GSE236581). The gene discussed is EDEM3; the disease is colorectal carcinoma.